Parvus Therapeutics

Parvus Therapeutics

Biotechnology, 800 Dubuque Ave, South San Francisco, California, 94080, United States, 11-50 Employees

parvustx.com

  • twitter
  • LinkedIn

phone no Phone Number: 41********

Who is PARVUS THERAPEUTICS

Parvus Therapeutics Inc. is a privately held biopharmaceutical company developing NavacimsTM, a platform technology based on foundational research published in 2016 (Nature 530:434), to t...

Read More

map
  • 800 Dubuque Ave, South San Francisco, California, 94080, United States Headquarters: 800 Dubuque Ave, South San Francisco, California, 94080, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • Peter Strumph CEO:   Peter Strumph

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from PARVUS THERAPEUTICS

Parvus Therapeutics Org Chart and Mapping

Peter Strumph

Chief Executive Officer

Employees

Joel Bruegger

Director of Protein Sciences and Process Development

Christopher Liang

Senior Research Associate II, Pharmacology

Jonathan Mejia

Research Associate I in Protein Sciences

Yiming Kang

Research Associate II

Janice Lee

Vice President, Development Management

Liz Belloli

Human Resources Manager

David Schisla

Senior Vice President - Technical Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Parvus Therapeutics

Answer: Parvus Therapeutics's headquarters are located at 800 Dubuque Ave, South San Francisco, California, 94080, United States

Answer: Parvus Therapeutics's phone number is 41********

Answer: Parvus Therapeutics's official website is https://parvustx.com

Answer: Parvus Therapeutics's revenue is $5 Million to $10 Million

Answer: Parvus Therapeutics's SIC: 2834

Answer: Parvus Therapeutics has 11-50 employees

Answer: Parvus Therapeutics is in Biotechnology

Answer: Parvus Therapeutics contact info: Phone number: 41******** Website: https://parvustx.com

Answer: Parvus Therapeutics Inc. is a privately held biopharmaceutical company developing NavacimsTM, a platform technology based on foundational research published in 2016 (Nature 530:434), to treat autoimmune diseases. Parvus mission is to shift the treatment paradigm toward Navacim-directed immune regulation, avoiding non-specific immune suppression associated with current therapies. Parvus innovative approach has the potential to benefit millions of patients suffering from debilitating autoimmune diseases and other chronic inflammatory conditions. Parvus is advancing a pipeline of proprietary drug candidates for multiple autoimmune indications through preclinical development and into the clinical. Parvus leadership team is experienced in successful drug discovery, development, manufacturing, regulatory approval, and commercialization.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access